StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Credit Suisse Upgrades Biogen (BIIB) to Outperform, After FDA Related Business Update
August 7, 2020 2:57 PM
Credit Suisse analyst Evan Seigerman upgraded Biogen (NASDAQ: BIIB) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Upgrades